Atlantic International Corp.
HealthcareNASDAQ:ATLN · NASDAQ Global Market
-$0.10 today
Vol 0.36M · Avg 0.44M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$59.4M +56.1% | -$135.5M -788.3% | -$15.3M -272.5% | -$4.1M -10.6% | -$3.7M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $210.5K -95.8% | $5.0M -0.9% | $5.0M +5629.3% | $87.9K +1.7% | $86.4K | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $0 -100.0% | $5.2M +201.9% | -$5.1M | $0 | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $36.1M -20.0% | $45.2M | $0 -100.0% | $256.9K -23.1% | $334.0K | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $10.2M -36.0% | $16.0M +7706.8% | $204.3K +231.5% | -$155.4K -229.5% | $120.0K | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | $2.4M +124.3% | -$9.9M -2481.6% | -$384.3K -2373.6% | -$15.5K -121.0% | $73.8K | $592.6M | $1.3B | $626.2M |
| Inventory | $0 | $0 | $0 +100.0% | -$20.7K +2.1% | -$21.1K | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $3.1M +150.9% | $1.2M +94.4% | $631.9K +353.8% | -$248.9K -2713.7% | $9.5K | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $4.7M -80.8% | $24.6M +57093.8% | -$43.2K -133.3% | $129.8K +124.8% | $57.7K | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $8.5M -85.4% | $58.1M +857.0% | $6.1M +2400.6% | $242.8K -79.3% | $1.2M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | -$4.4M +26.5% | -$6.0M +34.1% | -$9.1M -148.0% | -$3.7M -84.1% | -$2.0M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$66.8K +9.1% | -$73.5K +0.3% | -$73.7K -84.2% | -$40.0K -176.6% | -$14.5K | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 +100.0% | -$2.8M +30.2% | -$4.0M +32.8% | -$6.0M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 -100.0% | $6.9M +17.6% | $5.9M | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 | $0 +100.0% | -$4.1M | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$66.8K +9.1% | -$73.5K +0.3% | -$73.7K -104.0% | $1.8M +130.5% | -$6.0M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $3.9M +501.6% | -$962.5K -110.9% | $8.8M | $0 +100.0% | -$187.9K | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 -100.0% | $1.8M | $0 -100.0% | $13.8M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | $0 -100.0% | $6.3M +444.9% | -$1.8M | $0 +100.0% | -$1.6M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $3.9M -28.2% | $5.4M -38.8% | $8.8M | $0 -100.0% | $12.0M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 | $0 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$597.5K +11.4% | -$674.3K -85.6% | -$363.2K +80.2% | -$1.8M -145.7% | $4.0M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$4.5M +26.3% | -$6.1M +33.8% | -$9.2M -147.3% | -$3.7M -84.7% | -$2.0M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Prenetics Global Limited
NASDAQ:PRE
$367.72M
Anteris Technologies Global Corp.
NASDAQ:AVR
$336.61M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
$150.58M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Cassava Sciences, Inc.
SAVA
$63.77M
China SXT Pharmaceuticals, Inc.
SXTC
$1.99M
SEC Filings
Recent regulatory filings
No filings found.
Does ATLN generate free cash flow?
Atlantic International Corp. (ATLN) generated -$4,463,273.00 of free cash flow in fiscal 2025.
How much operating cash flow does ATLN produce?
Operating cash flow was -$4,396,505.00, before capital expenditures of $66,768.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.